Immune response to recombinant capsid proteins of adenovirus in humans: Antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity

Journal of Virology

Volumn 72, Issue 3, 1998, Pages 2388-2397

  Gahéry Ségard, Hanne ^a   Farace, Françoise ^b   Godfrin, Dominique ^a   Gaston, Jesintha ^a   Lengagne, Renée ^a   Tursz, Thomas ^b   Boulanger, Pierre ^c   Guillet, Jean Gérard ^a  

^a INSTITUT COCHIN   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; NEUTRALIZING ANTIBODY;

ADENOVIRUS; ARTICLE; GENE THERAPY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT;

EID: 2642702620     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.3.2388-2397.1998     Document Type: Article

References (35)

1. Bergelson, J. M., J. A. Cunningham, G. Droguett, E. A. Kurt-Jones, A. Krithivas, J. S. Hong, M. S. Horwitz, R. L. Crowell, and R. W. Finberg. 1997. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
2. Boudin, M.-L., and P. Boulanger. 1981. Antibody-triggered dissociation of adenovirus penton capsomer. Virology 113:781-786.
3. Gahéry-Ségard, H., V. Juillard, J. Gaston, R. Lengagne, A. Pavirani, P. Boulanger, and J.-G. Guillet. 1997. Humoral response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts. Eur. J. Immunol. 27:653-659.
4. Gahéry-Ségard, H., V. Molinier-Frenkel, C. Le Boulaire, P. Saulnier, P. Opolon, R. Lengagne, E. Gautier, A. Le Cesne, L. Zitvogel, A. Venet, C. Schatz, M. Courtney, T. Le Chevallier, T. Tursz, J.-G. Guillet, and F. Farace. 1997. Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products. J. Clin. Invest. 100:2218-2226.
5. Gallichan, W. S., D. C. Johnson, F. L. Graham, and K. L. Rosenthal. 1993. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J. Infect. Dis. 168:622-629.
6. Gilgenkrantz, H., D. Duboc, V. Juillard, D. Couton, A. Pavirani, J.-G. Guillet, P. Briand, and A. Kahn. 1995. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response. Hum. Gene Ther. 6:1265-1274.
7. Greber, U. F., M. Willetts, P. Webster, and A. Helenius. 1993. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75:477-486.
8. Hong, S. S., L. Karayan, J. Tournier, D. T. Curiel, and P. A. Boulanger. 1997. Adenovirus type 5 knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 16:2294-2306.
9. Horwitz, M. S. 1990. Adenoviridae and their replication, p. 1679-1721. In B. N. Fields (ed.), Virology. Raven Press, New York, N.Y.
10. Huang, S., R. I. Endo, and G. R. Nemerow. 1995. Upregulation of integrins avb3 and avb5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J. Virol. 69:2257-2263.
11. Juillard, V., P. Villefroy, D. Godfrin, A. Pavirani, A. Venet, and J.-G. Guillet 1995. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur. J. Immunol. 25:3467-3473.
12. Karayan, L., B. Gay, J. Gerfaux, and P. A. Boulanger. 1994. Oligomerization of recombinant penton base of adenovirus type 2 and its assembly with fiber in baculovirus-infected cells. Virology 202:782-795.
13. Llan, Y., R. Prakash, A. Davidson, V. Jona, G. Droguett, M. S. Hortwitz, N. Roy Chowdhury, and J. Roy Chowdhury. 1997. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. J. Clin. Invest. 99:1098-1106.
14. Mathias, P., T. Wickham, M. Moore, and G. Nemerow. 1994. Multiple adenovirus serotypes use αv integrins for infection. J. Virol. 68:6811-6814.
15. Novelli, A., and P. A. Boulanger. 1991. Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber. Virology 185:365-376.
16. Philipson, L., K. Lonberg-Holm, and U. Pettersson. 1968. Virus-receptor interaction in an adenovirus system. J. Virol. 2:1064-1075.
17. Quantin, B., L. D. Perricaudet, S. Tajbakhsh, and J.-L. Mandel. 1992. Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. USA 89:2581-2584.
18. Rosenecker, J., K.-H. Harms, R. M. Bertele, A. Pohl-Koppe, E. V. Mutius, D. Adam, and T. Nicolai. 1996. Adenovirus infection in cystic fibrosis patients: implications for the use of adenoviral vectors for gene transfer. Infection 24:5-8.
19. Rosenfeld, M. A., K. Yoshimura, B. C. Trapnell, K. Yoneyama, E. R. Rosenthal, W. Dalemans, M. Fukayama, J. Bargon, L. E. Stier, L. Stratford-Perricaudet, M. Perricaudet, W. B. Guggino, A. Pavirani, J.-P. Lecocq, and R. G. Crystal. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68:143-155.
20. Sparer, T. E., R. A. Tripp, D. L. Dillehay, T. W. Hermiston, W. S. M. Wold, and L. R. Gooding. 1996. The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. J. Virol. 70:2431-2439.
21. Stewart, P. L., C. Y. Chiu, S. Huang, T. Muir, Y. Zhoa, B. Chait, P. Mathias, and G. R. Nemerow. 1997. Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. EMBO J. 16: 1189-1198.
22. Stratford-Perricaudet, L. D., M. Levrero, J. F. Chasse, M. Perricaudet, and P. Briand. 1990. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1:241-256.
23. Stratford-Perricaudet, L. D., I. Makeh, M. Perricaudet, and P. Briand. 1992. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90:626-630.
24. Tomko, R. P., R. Xu, and L. Philipson. 1997. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. USA 94:3352-3356.
25. Toogood, C. I. A., J. Crompton, and R. T. Hay. 1992. Antipeptide antisera define neutralizing epitopes on the adenovirus hexon. J. Gen. Virol. 73:1429-1435.
26. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-550.
27. Tursz, T., A. Le Cesne, P. Baldeyrou, E. Gautier, P. Opolon, C. Schatz, A. Pavirani, M. Courtney, D. Lamy, T. Ragot, P. Saulnier, A. Andremont, R. Monier, M. Perricaudet, and T. Le Chevalier. 1997. Phase I study of a recombinant adenoviral-mediated gene transfer in lung cancer patients. J. Natl. Cancer Inst. 88:1857-1863.
28. Van Ginkel, F. W., C. Liu, J. W. Simecka, J. Y. Dong, T. Greenway, R. A. Frizzell, H. Kiyono, J. R. McGhee, and D. W. Pascual. 1995. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase. Hum. Gene Ther. 6:695-903.
29. Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
30. Wilson, J. M. 1993. Vehicles for gene therapy. Nature 365:691-692.
31. Wohlfart, C. 1988. Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms. J. Virol. 62:2321-2328.
32. Yang, Y., C. J. E. Hildegund, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.
33. Yang, Y., Q. Li, H. C. J. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
34. Yang, Y., G. Trinchieri, and J. M. Wilson. 1995. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat. Med. 1:890-893.
35. Zabner, J., B. W. Ramsey, D. P. Meeker, M. L. Aitken, R. Balfour, R. L. Gilson, J. Launspach, R. A. Moscicki, S. M. Richards, T. A. Standaert, J. Williams-Warren, S. C. Wadsworth, A. Smith, and M. J. Welsh. 1996. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J. Clin. Invest. 97:1504-1511.